Publications: DR Prerana Huddar
Huddar P, Graham K, Hubner R, Valle J, McNamara M
(
2023
)
.
P-285 Basket trials in upper gastrointestinal and hepato-pancreatico-biliary cancers – an emerging entity
.
Annals of Oncology
vol.
34
,
Anpalakhan S, Huddar P, Behrouzi R, Signori A, Cave J, Comins C, Cortellini A, Addeo A et al.
(
2023
)
.
Immunotherapy-related adverse events in real-world patients with advanced non-small cell lung cancer on chemoimmunotherapy: a Spinnaker study sub-analysis
.
Frontiers in Oncology
vol.
13
,
Anpalakhan S, Huddar P, Behrouzi R, Signori A, Cave J, Comins C, Cortellini A, Addeo A et al.
(
2023
)
.
76 Immunotherapy-related adverse events (irAEs) in real world patients with advanced non-small cell lung cancer (aNSCLC) on chemoimmunotherapy: a Spinnaker study sub-analysis
.
Lung Cancer
vol.
178
,
Anpalakhan S, Huddar P, Behrouzi R, Signori A, Cave J, Comins C, Cortellini A, Addeo A et al.
(
2023
)
.
The Effects of GCSF Primary Prophylaxis on Survival Outcomes and Toxicity in Patients with Advanced Non-Small Cell Lung Cancer on First-Line Chemoimmunotherapy: A Sub-Analysis of the Spinnaker Study
.
International Journal of Molecular Sciences
vol.
24
,
(
2
)
Wysocki O, Zhou C, Rogado J, Huddar P, Shotton R, Tivey A, Albiges L, Angelakas A et al.
(
2022
)
.
An International Comparison of Presentation, Outcomes and CORONET Predictive Score Performance in Patients with Cancer Presenting with COVID-19 across Different Pandemic Waves
.
Cancers
vol.
14
,
(
16
)
Lee RJ, Wysocki O, Zhou C, Shotton R, Tivey A, Lever L, Woodcock J, Albiges L et al.
(
2022
)
.
Establishment of CORONET, COVID-19 Risk in Oncology Evaluation Tool, to Identify Patients With Cancer at Low Versus High Risk of Severe Complications of COVID-19 Disease On Presentation to Hospital
.
JCO Clinical Cancer Informatics
vol.
6
,
(
6
)
Huddar P, Califano R
(
2021
)
.
Poly(Adenosine Diphosphate–Ribose) Polymerase Inhibition as Maintenance Treatment for SCLC: The Search Must Continue
.
Journal of Thoracic Oncology
vol.
16
,
(
8
)
1236
-
1238
.
Tivey A, Huddar P, Shotton R, Cheese I, Daniels S, Lorigan P, Lee RJ
(
2021
)
.
Patient engagement in melanoma research: from bench to bedside
.
Future Oncology
vol.
17
,
(
28
)
3705
-
3716
.
Lee R, Wysocki O, Zhou C, Calles A, Eastlake L, Ganatra S, Harrison M, Horsley L et al.
(
2021
)
.
CORONET; COVID-19 in Oncology evaluatiON Tool: Use of machine learning to inform management of COVID-19 in patients with cancer
.
Journal of Clinical Oncology
vol.
39
,
(
15_suppl
)
1505
-
1505
.
Lee RJ, Wysocki O, Bhogal T, Shotton R, Tivey A, Angelakas A, Aung T, Banfill K et al.
(
2021
)
.
Erratum to ‘Longitudinal characterisation of haematological and biochemical parameters in cancer patients prior to and during COVID-19 reveals features associated with outcome’ [ESMO Open Volume 6, Issue 1, February 2021, 100005]
.
ESMO Open
vol.
6
,
(
2
)
Lee R, Wysocki O, Zhou C, Shotton R, Tivey A, Lever L, Woodcock J, Angelakas A et al.
(
2021
)
.
Establishment of CORONET: COVID-19 Risk in Oncology Evaluation Tool to Identify Cancer Patients at Low Versus High Risk of Severe Complications of COVID-19 Infection Upon Presentation to Hospital
.
Lee RJ, Wysocki O, Bhogal T, Shotton R, Tivey A, Angelakas A, Aung T, Banfill K et al.
(
2020
)
.
Longitudinal characterisation of haematological and biochemical parameters in cancer patients prior to and during COVID-19 reveals features associated with outcome
.
ESMO Open
vol.
6
,
(
1
)
Lee R, Zhou C, Shotton R, Tivey A, Dickens E, Huddar P, McKenzie H, Boyce H et al.
(
2020
)
.
Development of a model to predict hospital admission and severe outcome in cancer patients with COVID-19
.
Annals of Oncology
vol.
31
,
Goode EF, Crawley D, Moss C, Okines A, Archer C, Gale J, Zaidi M, Howells JR et al.
(
2020
)
.
UK experience of the management of pregnancy associated breast cancer: A national retrospective review of practice
.
Annals of Oncology
vol.
31
,
Lee RJ, Zhou C, Wysocki O, Shotton R, Tivey A, Lever L, Woodcock J, Angelakas A et al.
.
Establishment of CORONET; COVID-19 Risk in Oncology Evaluation Tool to identify cancer patients at low versus high risk of severe complications of COVID-19 infection upon presentation to hospital
.
Tivey A, Shotton R, Taylor S, Oakley R, Summerton S, Huddar P, King M, Gibson J et al.
.
Remote monitoring of cancer patients with suspected Covid-19 using wearable sensors and regular mobile data networks; results of the RECAP feasibility study (NCT04397705)
.